A recent study showed that iNOS-derived NO from human and murine glioma M2-TAMs induced CDDP resistance by inhibiting acid sphingomyelinase (A-SMase), which otherwise stimulates apoptosis via death receptor CD95 [41]. This evidence concerns the gene SMPD1 and central nervous system cancer.